Drug Delivery Business

Medtronic studies highlight MiniMed 780G’s cost-effectiveness

Medtronic (NYSE: MDT) today announced new data demonstrating the health economic benefits of its MiniMed 780G system.
Seeking Alpha

Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy ...

GALWAY, Ireland, July 21, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the ...
FierceBiotech

England's NICE recommends hybrid closed-loop systems for Type 1 diabetes, prompting praise from Medtronic, Dexcom

The National Institute for Health and Care Excellence (NICE), England’s cost-effectiveness watchdog, has finalized a draft guidance regarding hybrid closed-loop systems, concluding that the technology ...
Nasdaq

Medtronic (MDT) Shares Positive Data for MiniMed 780G System

Medtronic plc MDT recently shared a comprehensive set of new data emphasizing the benefits of the MiniMed 780G insulin pump system. The latest findings demonstrate how the system addresses ...
Healio

Hybrid closed-loop system boosts time in range for pregnant women with type 1 diabetes

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of the CamAPS FX hybrid closed-loop system improved ...
FierceBiotech

ADA: Medtronic's MiniMed 780G insulin pump, simplified meal reporting help kids and teens better manage diabetes

It’s traditionally been particularly difficult to manage diabetes in highly active, still-developing children, but increasingly advanced glucose monitors and insulin delivery systems are aiming to ...